CARC-101C
/ Carcell Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 09, 2024
The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
New P1 trial • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 1
Of
1
Go to page
1